CHICAGO, Il. - U.S. health authorities are grappling with how to deal with the opioid epidemic's youngest patients.
A surge in infants born with withdrawal symptoms from their mothers' opioid use has outpaced science on how best to treat them.
Hospitals have a scattershot approach to treating their tremors, hard-to-soothe crying, diarrhea and other hallmark signs of newborn abstinence syndrome. And there are gaps in knowledge about risks they may face later on.
A new government-funded study aims to find some answers. With help from $1 million in National Institutes of Health funding, researchers are seeking to identify practices that could lead to a national treatment standard. A rigorous study comparing treatments and outcomes in hard-hit areas could start by the end of this year.